glp-1 drugs and inflammation tied to lower brain inflammation, higher depression risk The anti-inflammatory and immunological properties

The growing market reflects strong demand for safer, more approachable weight-loss options

A 2023 microneedle absorption study reported 134 nanomoles of GHK-Cu absorbed with microneedle-assisted delivery versus near-zero with topical alone a greater-than-20-fold gap

For instance, semaglutide received FDA and EMA approval for cardiovascular risk reduction in patients with obesity in 2024, and Novo Nordisk are also targeting the use of semaglutide in patients with obesity-related heart failure and metabolic associated steatohepatitis (MASH, formerly known as fatty liver disease)

And, glutathione supplementation with the combination of vitamin C and vitamin E can be a recipe for glowing skin